VENETOCLAX

62878 reported adverse events

Drug classes: BCL-2 Inhibitor [EPC]

These side effects are most commonly reported by patients taking VENETOCLAX:

# Side effect Count
0 DEATH 10347
1 OFF LABEL USE 7028
2 NEUTROPENIA 3635
3 FEBRILE NEUTROPENIA 3178
4 MYELOSUPPRESSION 3045
5 PLATELET COUNT DECREASED 2936
6 PYREXIA 2849
7 PNEUMONIA 2733
8 FATIGUE 2723
9 DIARRHOEA 2438
See all common reactions for VENETOCLAX

VENETOCLAX is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ALLOGENIC STEM CELL TRANSPLANTATION 85 0.5380
1 ACUTE MYELOID LEUKAEMIA REFRACTORY 76 0.4419
2 PLATELET TRANSFUSION 401 0.3113
3 CHRONIC LYMPHOCYTIC LEUKAEMIA RECURRENT 211 0.3027
4 ACUTE MYELOID LEUKAEMIA RECURRENT 615 0.2862
5 MINIMAL RESIDUAL DISEASE 118 0.2443
6 RED BLOOD CELL TRANSFUSION 87 0.2122
7 CHRONIC LYMPHOCYTIC LEUKAEMIA 778 0.1638
8 BONE MARROW TRANSPLANT 284 0.1496
9 MANTLE CELL LYMPHOMA 206 0.1353
See all enriched reactions for VENETOCLAX